^
    Back
    Association details:
    Biomarker:NUTM1-MXI1 rearrangement
    Cancer:Sarcoma
    Regimen:ICE
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: C4 – Case Studies
    Source:
    Diagn Cytopathol
    Title:

    Cytomorphology of NUTM1-rearranged sarcoma involving pleural fluid

    Published date:
    04/20/2022
    Excerpt:
    We describe an exceedingly rare cytology case of a NUTM1-rearranged sarcoma involving pleural fluid. A 48-year-old female...Extensive work-up including next generation sequencing (NGS) demonstrated a NUTM1:MXI1 rearranged sarcoma. The patient was first treated with ifosfamide, carboplatin, and etoposide (ICE) chemotherapy. She responded initially and then progressed...
    DOI:
    10.1002/dc.24968